|
RFC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.977800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.062800E-03 |
| Normal-vs-Stage2 |
4.61689999997628E-06 |
| Normal-vs-Stage3 |
2.961900E-04 |
| Normal-vs-Stage4 |
2.364200E-04 |
| Stage1-vs-Stage2 |
1.085560E-02 |
| Stage1-vs-Stage3 |
2.660800E-01 |
| Stage1-vs-Stage4 |
1.450620E-01 |
| Stage2-vs-Stage3 |
9.873700E-02 |
| Stage2-vs-Stage4 |
2.620200E-01 |
| Stage3-vs-Stage4 |
6.444800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.119820E-03 |
| Normal-vs-AfricanAmerican |
6.757800E-02 |
| Normal-vs-Asian |
8.177400E-03 |
| Caucasian-vs-AfricanAmerican |
8.173200E-01 |
| Caucasian-vs-Asian |
9.971600E-01 |
| AfricanAmerican-vs-Asian |
7.919000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.29680000000321E-05 |
| Normal-vs-Female |
7.954600E-04 |
| Male-vs-Female |
1.893220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.983800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.88790000005468E-06 |
| Normal-vs-Age(61-80Yrs) |
1.383140E-04 |
| Normal-vs-Age(81-100Yrs) |
2.202000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.715800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.669900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.438600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.541200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.931200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.032200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.916000E-01 |
| Classical-VS-Follicular |
4.08630000000576E-05 |
| Classical-VS-Other |
3.984000E-01 |
| Classical-VS-Normal |
1.359620E-02 |
| Tall-VS-Follicular |
5.396200E-03 |
| Tall-VS-Other |
2.375400E-01 |
| Tall-VS-Normal |
8.011900E-02 |
| Follicular-VS-Other |
6.915800E-01 |
| Follicular-VS-Normal |
1.70550000011538E-07 |
| Other-VS-Normal |
4.577600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.621400E-04 |
| Normal-vs-N1 |
3.624800E-03 |
| N0-vs-N1 |
7.640800E-01 |
|
|
